Covered recipient · General Payments record
RICHARD A PARISI
Allopathic & Osteopathic Physicians Internal Medicine Sleep Medicine
A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.
Saved only in this browser. No account or alerts.
General Payments · PY2025 · Entire year
$3,285.06
136 records · 0 disputed
“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”
— Centers for Medicare & Medicaid Services, Open Payments
A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.
These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.
A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Methodology & Data — sourcing, labeling, and limitations.
Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗
By nature of payment
PY2025 · entire year · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $3,285.06 | 136 |
By paying entity
PY2025 · entire year · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | $576.59 | 24 |
| GlaxoSmithKline, LLC. | $490.17 | 20 |
| JAZZ PHARMACEUTICALS INC. | $326.23 | 8 |
| Inspire Medical Systems, Inc. | $262.36 | 7 |
| Regeneron Healthcare Solutions, Inc. | $203.82 | 11 |
| HARMONY BIOSCIENCES LLC | $188.56 | 8 |
| Axsome Therapeutics, Inc. | $178.05 | 9 |
| Verona Pharma, Inc. | $173.86 | 9 |
| Viatris Specialty LLC | $154.54 | 8 |
| Avadel CNS Pharmaceuticals, LLC | $130.26 | 5 |
| GENZYME CORPORATION | $114.45 | 5 |
| Lilly USA, LLC | $98.15 | 5 |
| Insmed, Inc. | $82.51 | 4 |
| Amgen Inc. | $72.12 | 3 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $50.94 | 2 |
| PFIZER INC. | $36.89 | 2 |
| United Therapeutics Corporation | $30.99 | 1 |
| Actelion Pharmaceuticals US, Inc. | $29.03 | 1 |
| Resmed Corp | $26.59 | 1 |
| Pulmonx Corporation | $23.06 | 1 |
| Grifols USA, LLC | $21.56 | 1 |
| Electromed, Inc. | $14.33 | 1 |
Page 3 of 3; records 101–136 of 136 matching records. This page contains 36 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.
IndustryPayments · General Payments
RICHARD A PARISI
NPI 1104813765 · CMS profile ID 140305
Allopathic & Osteopathic Physicians / Internal Medicine / Sleep Medicine
WILLIAMSBURG, VA
A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.
A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.
General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types
Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00
Page 3 of 3; records 101–136 of 136 matching records. This page contains 36 records (maximum 50), not the full filtered export.
Filtered page: https://industrypayments.org/provider/npi-1104813765?year=2025&recipient=provider&page=3#records-h
CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e
Cite these filtered records
The citation includes this program year, filters, data edition, and page of results.
- Plain
- RICHARD A PARISI, NPI 1104813765, CMS profile ID 140305. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–136 of 136 matching records. This page contains 36 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1104813765?year=2025&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
- APA 7
- IndustryPayments. (2026). RICHARD A PARISI, NPI 1104813765, CMS profile ID 140305. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–136 of 136 matching records. This page contains 36 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1104813765?year=2025&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
- Bluebook
- RICHARD A PARISI, NPI 1104813765, CMS profile ID 140305, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 3; records 101–136 of 136 matching records. This page contains 36 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1104813765?year=2025&recipient=provider&page=3#records-h.
Centers for Medicare & Medicaid Services, Open Payments
Citation formats are provided for reference; check the requirements of your publication.
Payment records · PY2025
Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them
General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30
136 matching records · $3,285.06 reported total · 0 disputed
Nature of payment: All payment types
Records imported here (UTC).
CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.
Showing records 101–136 of 136.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Publication flags | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $20.87 | 04/09/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1206682561 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.05 | 04/08/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1206943371 | CMS |
| Viatris Specialty LLC | $18.82 | 04/07/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1238497277 | CMS |
| Resmed Corp | $26.59 | 04/02/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1214126204 | CMS |
| Axsome Therapeutics, Inc. | $16.85 | 03/27/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1235638392 | CMS |
| GlaxoSmithKline, LLC. | $26.80 | 03/26/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1190919582 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $33.01 | 03/24/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1222726229 | CMS |
| HARMONY BIOSCIENCES LLC | $22.77 | 03/20/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1222403424 | CMS |
| Inspire Medical Systems, Inc. | $74.36 | 03/19/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1251496801 | CMS |
| Verona Pharma, Inc. | $18.46 | 03/19/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1233755445 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.13 | 03/18/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1206551357 | CMS |
| JAZZ PHARMACEUTICALS INC. | $27.80 | 03/17/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1234325331 | CMS |
| Regeneron Healthcare Solutions, Inc. | $18.85 | 03/13/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1213006920 | CMS |
| Lilly USA, LLC | $18.12 | 03/12/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1186905814 | CMS |
| PFIZER INC. | $14.03 | 03/10/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1231592436 | CMS |
| AstraZeneca Pharmaceuticals LP | $22.96 | 03/06/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1206211211 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.92 | 03/05/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1207202868 | CMS |
| Inspire Medical Systems, Inc. | $39.33 | 03/04/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1251496799 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.03 | 02/26/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1206151209 | CMS |
| Viatris Specialty LLC | $20.92 | 02/26/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1238496237 | CMS |
| Axsome Therapeutics, Inc. | $20.81 | 02/24/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1235360489 | CMS |
| Verona Pharma, Inc. | $17.56 | 02/17/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1233755465 | CMS |
| Amgen Inc. | $26.43 | 02/12/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1228687416 | CMS |
| JAZZ PHARMACEUTICALS INC. | $32.42 | 02/11/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1234319898 | CMS |
| Regeneron Healthcare Solutions, Inc. | $20.61 | 02/10/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1213006918 | CMS |
| GlaxoSmithKline, LLC. | $23.00 | 02/04/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1191031610 | CMS |
| Inspire Medical Systems, Inc. | $33.53 | 02/04/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1251496797 | CMS |
| Viatris Specialty LLC | $23.17 | 02/03/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1238489482 | CMS |
| Pulmonx Corporation | $23.06 | 01/28/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1199545809 | CMS |
| Axsome Therapeutics, Inc. | $11.79 | 01/27/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1235360478 | CMS |
| GlaxoSmithKline, LLC. | $23.34 | 01/22/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1190682963 | CMS |
| JAZZ PHARMACEUTICALS INC. | $125.76 | 01/22/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1234306022 | CMS |
| Regeneron Healthcare Solutions, Inc. | $27.64 | 01/15/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1213006916 | CMS |
| Grifols USA, LLC | $21.56 | 01/14/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1249581126 | CMS |
| Verona Pharma, Inc. | $24.74 | 01/13/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1233755477 | CMS |
| Amgen Inc. | $19.23 | 01/08/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1228687414 | CMS |
By program year
All program years on this page · sorted by year
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.
Research Payments
One row per program year and role, newest year first · amounts for the two roles are never added together
| Program year | Role | Amount | Records |
|---|---|---|---|
| PY2025 | Principal investigator | $533,349.42 | 36 |
| PY2024 | Principal investigator | $92,512.67 | 22 |
| PY2023 | Principal investigator | $18,772.46 | 12 |
| PY2022 | Principal investigator | $5,865.30 | 1 |
Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.
“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”
— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224
Research Payments records · PY2025
Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them
36 records in PY2025
| Role | Paying entity | Amount | Date | Recipient | Study | Dispute status | Published | Record ID |
|---|---|---|---|---|---|---|---|---|
| Principal investigator 1 | Avadel CNS Pharmaceuticals, LLC | $21,206.06 | 12/31/2025 | Covered Recipient Teaching Hospital CLEVELAND CLINIC HOSPITAL | A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED WITHDRAWAL, MULTICENTER STUDY OF THE EFFICACY AND SAFETY OF FT218 IN THE TREATMENT OF IDIOPATHIC HYPERSOMNIA (IH) | No dispute reported | 06/30/2026 | 1208554175 |
| Principal investigator 1 | Avadel CNS Pharmaceuticals, LLC | $97,616.47 | 12/31/2025 | Non-covered Recipient Entity TPMG CLINICAL RESEARCH WILLIAMSBURG | A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED WITHDRAWAL, MULTICENTER STUDY OF THE EFFICACY AND SAFETY OF FT218 IN THE TREATMENT OF IDIOPATHIC HYPERSOMNIA (IH) | No dispute reported | 06/30/2026 | 1208554211 |
| Principal investigator 1 | Avadel CNS Pharmaceuticals, LLC | $78,717.55 | 12/31/2025 | Non-covered Recipient Entity CLAYTON SLEEP INSTITUTE LLC | A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED WITHDRAWAL, MULTICENTER STUDY OF THE EFFICACY AND SAFETY OF FT218 IN THE TREATMENT OF IDIOPATHIC HYPERSOMNIA (IH) | No dispute reported | 06/30/2026 | 1208554213 |
| Principal investigator 1 | Avadel CNS Pharmaceuticals, LLC | $21,500.00 | 12/31/2025 | Non-covered Recipient Entity VELOCITY CLINICAL RESEARCH INC | A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED WITHDRAWAL, MULTICENTER STUDY OF THE EFFICACY AND SAFETY OF FT218 IN THE TREATMENT OF IDIOPATHIC HYPERSOMNIA (IH) | No dispute reported | 06/30/2026 | 1208554215 |
| Principal investigator 1 | Avadel CNS Pharmaceuticals, LLC | $13,500.00 | 12/31/2025 | Non-covered Recipient Entity PHOENIX MEDICAL GROUP PC | A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED WITHDRAWAL, MULTICENTER STUDY OF THE EFFICACY AND SAFETY OF FT218 IN THE TREATMENT OF IDIOPATHIC HYPERSOMNIA (IH) | No dispute reported | 06/30/2026 | 1208554217 |
| Principal investigator 1 | Avadel CNS Pharmaceuticals, LLC | $97,698.62 | 12/31/2025 | Non-covered Recipient Entity UNIVERSITY OF KANSAS MEDICAL CENTER RESEARCH INSTITUTE INC DBA KUMC RESEARCH INSTITUTE | A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED WITHDRAWAL, MULTICENTER STUDY OF THE EFFICACY AND SAFETY OF FT218 IN THE TREATMENT OF IDIOPATHIC HYPERSOMNIA (IH) | No dispute reported | 06/30/2026 | 1208554219 |
| Principal investigator 1 | Avadel CNS Pharmaceuticals, LLC | $41,505.43 | 12/31/2025 | Non-covered Recipient Entity STATE OF WEST VIRGINIA DBA WEST VIRGINIA UNIVERSITY | A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED WITHDRAWAL, MULTICENTER STUDY OF THE EFFICACY AND SAFETY OF FT218 IN THE TREATMENT OF IDIOPATHIC HYPERSOMNIA (IH) | No dispute reported | 06/30/2026 | 1208554221 |
| Principal investigator 1 | Teva Pharmaceuticals USA, Inc. | $6,419.93 | 12/11/2025 | Non-covered Recipient Entity TIDEWATER PHYSICIANS MULTISPECIALTY GROUP PC | A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma | No dispute reported | 06/30/2026 | 1244046970 |
| Principal investigator 1 | Verona Pharma, Inc. | $24,411.24 | 11/07/2025 | Non-covered Recipient Entity TIDEWATER PHYSICIANS MULTISPEC | Verona | No dispute reported | 06/30/2026 | 1232892223 |
| Principal investigator 1 | GlaxoSmithKline, LLC. | $2,601.90 | 10/17/2025 | Non-covered Recipient Entity TIDEWATER PHYSICIANS MULTISPECIALTY GROUP PC | A PHASE 3, 52-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARA | No dispute reported | 06/30/2026 | 1192183951 |
| Principal investigator 1 | AstraZeneca Pharmaceuticals LP | $433.80 | 10/08/2025 | Non-covered Recipient Entity TIDEWATER PHYSICIANS MULTISPECIALTY GROUP YORKTOWN FAMILY MEDICINE | A 24-Week Efficacy and Safety Study to Assess Budesonide and Formoterol Fumarate Metered Dose Inhaler in Adult and Adolescent Participants With Inadequately Controlled Asthma | No dispute reported | 06/30/2026 | 1185552917 |
| Principal investigator 1 | Verona Pharma, Inc. | $350.00 | 09/17/2025 | Non-covered Recipient Entity TIDEWATER PHYSICIANS MULTISPEC | Verona | No dispute reported | 06/30/2026 | 1232892128 |
| Principal investigator 1 | Verona Pharma, Inc. | $500.00 | 09/17/2025 | Non-covered Recipient Entity TIDEWATER PHYSICIANS MULTISPEC | Verona | No dispute reported | 06/30/2026 | 1232892130 |
| Principal investigator 1 | Verona Pharma, Inc. | $1,000.00 | 09/17/2025 | Non-covered Recipient Entity TIDEWATER PHYSICIANS MULTISPEC | Verona | No dispute reported | 06/30/2026 | 1232892132 |
| Principal investigator 1 | GlaxoSmithKline, LLC. | $1,421.10 | 09/03/2025 | Non-covered Recipient Entity TIDEWATER PHYSICIANS MULTISPECIALTY GROUP PC | A PHASE 3, 52-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARA | No dispute reported | 06/30/2026 | 1192183923 |
| Principal investigator 1 | GlaxoSmithKline, LLC. | $1,718.00 | 08/25/2025 | Non-covered Recipient Entity TIDEWATER PHYSICIANS MULTISPECIALTY GROUP PC | A 52-WEEK, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, MUL | No dispute reported | 06/30/2026 | 1192181728 |
| Principal investigator 1 | GlaxoSmithKline, LLC. | $2,901.00 | 08/25/2025 | Non-covered Recipient Entity TIDEWATER PHYSICIANS MULTISPECIALTY GROUP PC | A 52-WEEK, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, MUL | No dispute reported | 06/30/2026 | 1192181737 |
| Principal investigator 1 | Verona Pharma, Inc. | $350.00 | 08/08/2025 | Non-covered Recipient Entity TIDEWATER PHYSICIANS MULTISPEC | Verona | No dispute reported | 06/30/2026 | 1232892126 |
| Principal investigator 1 | AstraZeneca Pharmaceuticals LP | $17,500.00 | 08/07/2025 | Non-covered Recipient Entity TIDEWATER PHYSICIANS MULTISPECIALTY GROUP YORKTOWN FAMILY MEDICINE | Randomized, Double-blind, Placebo-controlled, Parallel Group, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Tezepelumab in Adult Participants with Moderate to Very Severe Chronic Obstructive Pulmonary Disease COPD | No dispute reported | 06/30/2026 | 1185552911 |
| Principal investigator 1 | GlaxoSmithKline, LLC. | $674.10 | 08/04/2025 | Non-covered Recipient Entity TIDEWATER PHYSICIANS MULTISPECIALTY GROUP PC | A PHASE 3, 52-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARA | No dispute reported | 06/30/2026 | 1192152238 |
| Principal investigator 1 | GlaxoSmithKline, LLC. | $2,095.20 | 07/23/2025 | Non-covered Recipient Entity TIDEWATER PHYSICIANS MULTISPECIALTY GROUP PC | A PHASE 3, 52-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARA | No dispute reported | 06/30/2026 | 1192183917 |
| Principal investigator 1 | GlaxoSmithKline, LLC. | $1,119.60 | 06/20/2025 | Non-covered Recipient Entity TIDEWATER PHYSICIANS MULTISPECIALTY GROUP PC | A PHASE 3, 52-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARA | No dispute reported | 06/30/2026 | 1192183933 |
| Principal investigator 1 | Verona Pharma, Inc. | $4,798.21 | 06/18/2025 | Non-covered Recipient Entity TIDEWATER PHYSICIANS MULTISPEC | Verona | No dispute reported | 06/30/2026 | 1232892092 |
| Principal investigator 1 | Verona Pharma, Inc. | $1,350.00 | 06/13/2025 | Non-covered Recipient Entity TIDEWATER PHYSICIANS MULTISPEC | Verona | No dispute reported | 06/30/2026 | 1232892100 |
| Principal investigator 1 | GlaxoSmithKline, LLC. | $700.00 | 06/06/2025 | Non-covered Recipient Entity TIDEWATER PHYSICIANS MULTISPECIALTY GROUP PC | A PHASE 3, 52-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARA | No dispute reported | 06/30/2026 | 1192181733 |
| Principal investigator 1 | AstraZeneca Pharmaceuticals LP | $36,370.90 | 05/23/2025 | Non-covered Recipient Entity TIDEWATER PHYSICIANS MULTISPECIALTY GROUP YORKTOWN FAMILY MEDICINE | A Phase III, Multicentre, Randomised, Double-blind, Chronic-dosing, Parallel-group, Placebo-controlled Extension Study to Evaluate the Long-term Efficacy and Safety of Tozorakimab (MEDI3506) in Participants with Chronic Obstructive Pulmonary Disease (COPD) with a History of Exacerbations | No dispute reported | 06/30/2026 | 1185552909 |
| Principal investigator 1 | GlaxoSmithKline, LLC. | $2,182.50 | 05/21/2025 | Non-covered Recipient Entity TIDEWATER PHYSICIANS MULTISPECIALTY GROUP PC | A PHASE 3, 52-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARA | No dispute reported | 06/30/2026 | 1192152234 |
| Principal investigator 1 | Verona Pharma, Inc. | $15,338.87 | 05/02/2025 | Non-covered Recipient Entity TIDEWATER PHYSICIANS MULTISPEC | Verona | No dispute reported | 06/30/2026 | 1232892090 |
| Principal investigator 1 | Verona Pharma, Inc. | $10,500.00 | 04/01/2025 | Non-covered Recipient Entity TIDEWATER PHYSICIANS MULTISPEC | Verona | No dispute reported | 06/30/2026 | 1232892102 |
| Principal investigator 1 | AstraZeneca Pharmaceuticals LP | $2,507.61 | 03/24/2025 | Non-covered Recipient Entity TIDEWATER PHYSICIANS MULTISPECIALTY GROUP YORKTOWN FAMILY MEDICINE | The CHRONICLE Study is a multi center,non interventional,prospective cohort study of adults with severe asthma who do not achieve control with high-dose ICS therapy with additional controllers and or require systemic corticosteroid or monoclonal antibod | No dispute reported | 06/30/2026 | 1185552913 |
| Principal investigator 1 | GlaxoSmithKline, LLC. | $438.30 | 02/25/2025 | Non-covered Recipient Entity TIDEWATER PHYSICIANS MULTISPECIALTY GROUP PC | A PHASE 3, 52-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARA | No dispute reported | 06/30/2026 | 1192181724 |
| Principal investigator 1 | Teva Pharmaceuticals USA, Inc. | $204.60 | 02/24/2025 | Non-covered Recipient Entity TIDEWATER PHYSICIANS MULTISPECIALTY GROUP PC | A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma | No dispute reported | 06/30/2026 | 1244046996 |
| Principal investigator 1 | AstraZeneca Pharmaceuticals LP | $17,519.08 | 02/19/2025 | Non-covered Recipient Entity TIDEWATER PHYSICIANS MULTISPECIALTY GROUP YORKTOWN FAMILY MEDICINE | A Phase III, Multicentre, Randomised, Double-blind, Chronic-dosing, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Two Dose Regimens of MEDI3506 | No dispute reported | 06/30/2026 | 1185552915 |
| Principal investigator 1 | GlaxoSmithKline, LLC. | $1,557.90 | 01/24/2025 | Non-covered Recipient Entity TIDEWATER PHYSICIANS MULTISPECIALTY GROUP PC | A PHASE 3, 52-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARA | No dispute reported | 06/30/2026 | 1192183928 |
| Principal investigator 1 | Verona Pharma, Inc. | $1,500.00 | 01/17/2025 | Non-covered Recipient Entity TIDEWATER PHYSICIANS MULTISPEC | Verona | No dispute reported | 06/30/2026 | 1232892052 |
| Principal investigator 1 | Teva Pharmaceuticals USA, Inc. | $3,141.45 | 01/16/2025 | Non-covered Recipient Entity TIDEWATER PHYSICIANS MULTISPECIALTY GROUP PC | A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma | No dispute reported | 06/30/2026 | 1244046968 |